Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Air Products and Chemicals
APD
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Segments
By product
See full
Financing and Lease Arrangement
1%
0.0%
Other financials
Income statement
See full
Revenue
$3.2B
+8.8%
Gross profit
$987.4M
+14.5%
Operating income
$752.7M
+132%
Net income
$710.4M
+141%
EPS (diluted)
$3.19
+141%
Balance sheet
See full
Cash & equivalents
$951.0M
-36.2%
Total debt
$914.5M
-35.2%
Total equity
$15.6B
+6.4%
Total assets
$41.6B
+7.1%
Cash flow
See full
Operating cash flow
$1.1B
+236%
CapEx
$1.1B
-41.4%
Free cash flow
-$3.9M
+99.8%
Valuation
See full
Market cap
$62.34B
+3.5%
Enterprise value
$62.3B
+3.6%
P/E
29.7×
-9.6×
P/S
5×
0.0×
Profitability
See full
Gross margin
32%
0.0pp
Operating margin
18.3%
+6.0pp
Net margin
16.9%
+4.1pp
FCF margin
-10%
-4.2pp
Returns & leverage
See full
Return on equity
13.9%
+3.5pp
Debt / equity
0.1×
0.0×
Current ratio
1.4×
+0.4×